(Q37417444)

English

Stimulation of cholecystokinin-A receptors with Gl181771X: a failed clinical trial that did not test the pharmacogenetic hypothesis for reduction of food intake

scientific article published on April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Stimulation of cholecystokinin-A receptors with Gl181771X: a failed clinical trial that did not test the pharmacogenetic hypothesis for reduction of food intake (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

cholecystokinin

1 reference

based on heuristic

inferred from title

author name string

A D Roses

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

1 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

362-365

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

https://scigraph.springernature.com/pub.10.1038/clpt.2008.192

0 references

Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Gastrointestinal satiety signals II. Cholecystokinin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

CCK-8 activates hepatic vagal C-fiber afferents.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Pharmacogenetics and drug development: the path to safer and more effective drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

SNP haplotype tagging from DNA pools of two individuals

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Paving the critical path: how can clinical pharmacology help achieve the vision?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Pharmacogenetics in drug discovery and development: a translational perspective

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Trends in development and approval times for new therapeutics in the United States

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

21 January 2018

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2008.192

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37417444&oldid=2179518338"